Overview
CARE9’s Oncology Solutions represent our flagship vertical, delivering comprehensive cancer care infrastructure through the Indo-African Oncology Institute (IAOI) framework—250-bed tertiary oncology hospitals equipped with Linear Accelerators, PET-CT, molecular diagnostics, and tele-oncology platforms.
Indo-African Oncology Institute (IAOI) Framework
Infrastructure Components
Radiation Oncology
- Linear Accelerators (LINACs) with IMRT/VMAT capabilities
- Brachytherapy units
- Radiopharmacy facilities
- Treatment planning systems
Medical Oncology
- Chemotherapy day-care centers (50+ chairs)
- Oncology ICUs
- Bone marrow transplant units
- Palliative care wards
Surgical Oncology
- Dedicated oncology operation theaters
- Minimally invasive surgery capabilities
- Reconstructive surgery units
- 24/7 emergency oncology services
Diagnostic & Laboratory
- PET-CT and advanced imaging
- Molecular oncology labs
- NGS (Next Generation Sequencing)
- Liquid biopsy capabilities
- Immunohistochemistry
Digital Integration
Tele-Oncology Platform
- Remote tumor board consultations
- Second opinion services
- International expert collaboration
- Patient follow-up and monitoring
Cancer Registry
- National cancer data collection
- Epidemiological research
- Treatment outcome tracking
- Policy planning support
Mobile Screening Units
- Community-based early detection
- Rural outreach programs
- Breast and cervical cancer screening
- Health education campaigns
Impact Metrics (Projected per Institute)
- 100,000+ Patients screened annually
- 10,000+ New cancer cases treated per year
- 30-40% Reduction in outbound medical travel
- 1000+ Direct jobs created
- 500+ Healthcare workers trained
- National Cancer registry establishment
Service Offerings
Clinical Services
- Multi-disciplinary tumor boards
- Precision oncology and genomic testing
- Clinical trial participation
- Survivorship programs
- Psycho-oncology support
Training & Capacity Building
- Oncology fellowship programs
- Nursing specialization in cancer care
- Radiotherapy technician certification
- Research methodology training
Research & Innovation
- Translational cancer research
- Real-world evidence generation
- Health economics studies
- Quality of life assessments
Financial Model
PPP/BOOT Structure
- Total Investment: $80-120M per 250-bed facility
- Implementation Timeline: 24-30 months
- Operational Phase: 20-30 years
- Transfer: To government post-concession
Capital Stack
- DFI debt (50-60%)
- Export credit agency finance (20-30%)
- Sponsor equity (15-20%)
- Government contribution (land, licensing)
Revenue Streams
- Government long-term agreements
- National health insurance schemes
- Corporate partnerships
- International patient services
- Training and certification programs
Regional Expansion Plan
Phase 1: Flagship Institutes (2024-2026)
- Ghana (Accra): $100M flagship IAOI
- Zimbabwe (Harare): 250-bed facility
- Nigeria (Lagos): 300-bed comprehensive center
Phase 2: Hub Expansion (2026-2028)
- Côte d’Ivoire, Senegal, Kenya
- Brazil (São Paulo), Colombia (Bogotá)
- Eastern Europe expansion
Target by 2028
- 1000+ Oncology beds operational
- 6+ Countries with IAOI facilities
- 500,000+ Patients served
- 30% Reduction in medical travel across regions
Quality & Accreditation
- JCI (Joint Commission International) accreditation pathway
- IAEA (International Atomic Energy Agency) certification
- CAP (College of American Pathologists) lab accreditation
- ASCO (American Society of Clinical Oncology) guidelines compliance
Partnerships
- International cancer centers for knowledge transfer
- Pharmaceutical companies for clinical trials
- Medical equipment manufacturers
- Global oncology societies
- Patient advocacy organizations